RAG1 p.Phe5Leu
c.15C>G · rs745600099 · VCV971195
ClinGen expert panel — Severe Combined Immunodeficiency Disease VCEP
Uncertain Significance for recombinase activating gene 1 deficiency. Applied ACMG criteria (verbatim):
PM2_Supporting
Curation rationale (ClinGen, verbatim)
The NM_000448.3:c.15C>G variant in RAG1 is a missense variant predicted to cause a substitution of phenylalanine by leucine at amino acid 5 (p.Phe5Leu). The Popmax filtering allele frequency of this variant in gnomAD v2.1.1 is 0.00000292, which is lower than the SCID-VCEP’s threshold for PM2 (<0.000102). No homozygous individual has been observed in the gnomAD v2.1.1 (PM2_Supporting). This variant has not been reported in the literature in individuals with SCID. In ClinVar, the variant was reported in one affected individual who didn't have a second RAG1 variant, and the variant was classified as a Variant of Uncertain Significance (Invitae, SCV001420312.4). There is no functional evidence for this variant. Due to insufficient evidence, this variant is classified as a variant of uncertain significance for SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: PM2_supporting (SCID VCEP specifications version 1.0).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1961 | likely benign |
|---|---|---|
| REVEL | 0.104 | moderately benign-leaning |
| SaProt | LLR -4.48 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.7 | GERP 0.43, phastCons 1 |
| Regional constraint | o/e 1.10 | unconstrained · MANE · 814 bp · p 0.066 · regional, not allelic |
| Overall | ||
| CADD | 11.25 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RAG1
- Protein
- p.Phe5Leu
- Coding
- c.15C>G
- MANE Select
- NM_000448
- dbSNP
- rs745600099
- Type
- single nucleotide variant
- Location
- chr11:36573319 (GRCh38)
- Gene constraint
- LOEUF 0.703 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.68
- Residue 5
- the 'interaction with importin alpha-1' region
Disease context
recombinase activating gene 1 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: combined immunodeficiency with skin granulomassevere combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positiveOmenn syndrome
Similar variants
- RAG1 p.Ala444Val Pathogenic ★★★ same condition
- RAG1 p.Arg108Ter Pathogenic ★★★ same condition
- RAG1 p.Arg142Ter Pathogenic ★★★ same condition
- RAG1 p.Arg394Gln Likely pathogenic ★★★ same condition
- RAG1 p.Arg394Trp Pathogenic ★★★ same condition
- RAG1 p.Arg396His Pathogenic ★★★ same condition
- RAG1 p.Arg404Gln Pathogenic ★★★ ⚠ same condition
- RAG1 p.Arg561Cys Pathogenic ★★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rag1-p-phe5leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown